Allogeneic adipose tissue-derived mesenchymal stromal cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic adipose tissue-derived mesenchymal stromal cells, covering 2024-12-09 to 2026-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis [Phase 1]